Jasper Therapeutics Inc

Jasper Therapeutics Inc is a biotech firm based in Redwood City, California, focusing on innovative treatments in the realm of stem cell transplantation and gene therapies. It's at the forefront with its lead product, briquilimab, aimed at preparing patients for stem cell or gene therapy by clearing hematopoietic stem cells from the bone marrow. Additionally, Jasper is pioneering in developing engineered stem cells to enhance the effectiveness of both allogeneic and autologous gene-edited stem cell grafts, targeting a range of diseases including chronic spontaneous urticaria and myelodysplastic syndrome.